Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 6, 2026, 3:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Progesterone vaginal insert Clear all

Conditions: Polycystic Ovarian Syndrome, Infertility
Interventions: Menotropin, Progesterone vaginal insert, Follitropin beta, Progesterone in oil, leuprolide acetate; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 6
States / cities: Littleton, Colorado • Clearwater, Florida • Chicago, Illinois + 3 more

Conditions: Short Cervical Length
Interventions: Vaginal progesterone, Placebo, Arabin Pessary; Drug · Device
Lead sponsor: The George Washington University Biostatistics Center; Other
Eligibility: Female only
Enrollment: 1,311 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 16
States / cities: Birmingham, Alabama • San Francisco, California • Denver, Colorado + 12 more

Conditions: NASH - Nonalcoholic Steatohepatitis
Interventions: Estradiol patch, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Progesterone Supplementation in Women Undergoing ART
Interventions: Progesterone vaginal ring; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 15
States / cities: Tempe, Arizona • Encino, California • Newark, Delaware + 12 more

Conditions: Infertility
Interventions: Endometrin® plus Progesterone in Oil (PIO), Progesterone in Oil (PIO) Only; Drug
Lead sponsor: Shady Grove Fertility Reproductive Science Center; Other
Eligibility: 18 Years to 48 Years · Female only
Enrollment: 1,139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 14
States / cities: Washington D.C., District of Columbia • Annapolis, Maryland • Baltimore, Maryland + 10 more

Conditions: Premature Birth
Interventions: Cervical cerclage, Vaginal progesterone; Procedure · Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preterm Birth
Interventions: Cup pessary (Bioteque America, Inc); Device
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2011
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: Infertility
Interventions: Menotropin, Progestrone vaginal insert, follitropin beta, Progesterone in oil, Ganirelix; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 7
States / cities: Pasadena, California • San Diego, California • Littleton, Colorado + 4 more

Conditions: Infertility, Pregnancy
Interventions: Crinone vaginal progesterone gel, Placebo vaginal gel; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Congenital Heart Disease, Periventricular Leucomalacia, Brain Development, Cardiac Surgery, Neurodevelopmental Disability, Fetal Neuroprotection
Interventions: Progesterone, Vaginal lubricant; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Not listed
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Polycystic Ovarian Syndrome
Interventions: Endometrin (progesterone 100mg vaginal inserts), Metformin; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Preterm Labor, Preterm Birth
Interventions: Multimodal intervention strategy; Other
Lead sponsor: Sera Prognostics, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 6,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 18
States / cities: San Diego, California • New Haven, Connecticut • Newark, Delaware + 15 more

Conditions: Metrorrhagia
Interventions: Femring®, DepoProvera ®; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Focus: Prevent Preterm Delivery, Incidental Short Cervix at Mid-trimester
Interventions: Arabin Pessary; Drug
Lead sponsor: University of Illinois at Chicago; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Premature Birth
Interventions: Cervical cerclage, Vaginal Suppository Progesterone; Procedure · Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 329 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 2
States / cities: Charlotte, North Carolina • Philadelphia, Pennsylvania

Search by objective public record fields.

Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix

Estrogen Administration for the Treatment of NASH in Postmenopausal Women

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer

Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix

Preventing Preterm Birth With a Pessary

MENOPUR® Versus FOLLISTIM®

Sexual Absorption of Vaginal Progesterone

Randomized Trial of Maternal Progesterone Therapy

Endometrial Effects of Metformin Action in Women With Polycystic Ovarian Syndrome (PCOS)

Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies

LATe Cerclage in High-risk Pregnancies (LATCH)